Cargando…

High phosphorylated cyclin-dependent kinase 2 expression indicates poor prognosis of luminal androgen receptor triple-negative breast cancer: pCDK2 in luminal androgen receptor TNBC

Detalles Bibliográficos
Autores principales: Jin, Zining, Zhang, Qingfu, Wang, Chunyu, Wang, Shengli, Lin, Lin, Zou, Renlong, Sun, Ge, Zeng, Kai, Zhou, Baosheng, Tong, Yuxin, Chen, Bo, Zhao, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827805/
https://www.ncbi.nlm.nih.gov/pubmed/35838199
http://dx.doi.org/10.3724/abbs.2022083
_version_ 1784867124629471232
author Jin, Zining
Zhang, Qingfu
Wang, Chunyu
Wang, Shengli
Lin, Lin
Zou, Renlong
Sun, Ge
Zeng, Kai
Zhou, Baosheng
Tong, Yuxin
Chen, Bo
Zhao, Yue
author_facet Jin, Zining
Zhang, Qingfu
Wang, Chunyu
Wang, Shengli
Lin, Lin
Zou, Renlong
Sun, Ge
Zeng, Kai
Zhou, Baosheng
Tong, Yuxin
Chen, Bo
Zhao, Yue
author_sort Jin, Zining
collection PubMed
description
format Online
Article
Text
id pubmed-9827805
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-98278052023-02-10 High phosphorylated cyclin-dependent kinase 2 expression indicates poor prognosis of luminal androgen receptor triple-negative breast cancer: pCDK2 in luminal androgen receptor TNBC Jin, Zining Zhang, Qingfu Wang, Chunyu Wang, Shengli Lin, Lin Zou, Renlong Sun, Ge Zeng, Kai Zhou, Baosheng Tong, Yuxin Chen, Bo Zhao, Yue Acta Biochim Biophys Sin (Shanghai) Research Article Oxford University Press 2022-07-14 /pmc/articles/PMC9827805/ /pubmed/35838199 http://dx.doi.org/10.3724/abbs.2022083 Text en © The Author(s) 2021. https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/).
spellingShingle Research Article
Jin, Zining
Zhang, Qingfu
Wang, Chunyu
Wang, Shengli
Lin, Lin
Zou, Renlong
Sun, Ge
Zeng, Kai
Zhou, Baosheng
Tong, Yuxin
Chen, Bo
Zhao, Yue
High phosphorylated cyclin-dependent kinase 2 expression indicates poor prognosis of luminal androgen receptor triple-negative breast cancer: pCDK2 in luminal androgen receptor TNBC
title High phosphorylated cyclin-dependent kinase 2 expression indicates poor prognosis of luminal androgen receptor triple-negative breast cancer: pCDK2 in luminal androgen receptor TNBC
title_full High phosphorylated cyclin-dependent kinase 2 expression indicates poor prognosis of luminal androgen receptor triple-negative breast cancer: pCDK2 in luminal androgen receptor TNBC
title_fullStr High phosphorylated cyclin-dependent kinase 2 expression indicates poor prognosis of luminal androgen receptor triple-negative breast cancer: pCDK2 in luminal androgen receptor TNBC
title_full_unstemmed High phosphorylated cyclin-dependent kinase 2 expression indicates poor prognosis of luminal androgen receptor triple-negative breast cancer: pCDK2 in luminal androgen receptor TNBC
title_short High phosphorylated cyclin-dependent kinase 2 expression indicates poor prognosis of luminal androgen receptor triple-negative breast cancer: pCDK2 in luminal androgen receptor TNBC
title_sort high phosphorylated cyclin-dependent kinase 2 expression indicates poor prognosis of luminal androgen receptor triple-negative breast cancer: pcdk2 in luminal androgen receptor tnbc
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827805/
https://www.ncbi.nlm.nih.gov/pubmed/35838199
http://dx.doi.org/10.3724/abbs.2022083
work_keys_str_mv AT jinzining highphosphorylatedcyclindependentkinase2expressionindicatespoorprognosisofluminalandrogenreceptortriplenegativebreastcancerpcdk2inluminalandrogenreceptortnbc
AT zhangqingfu highphosphorylatedcyclindependentkinase2expressionindicatespoorprognosisofluminalandrogenreceptortriplenegativebreastcancerpcdk2inluminalandrogenreceptortnbc
AT wangchunyu highphosphorylatedcyclindependentkinase2expressionindicatespoorprognosisofluminalandrogenreceptortriplenegativebreastcancerpcdk2inluminalandrogenreceptortnbc
AT wangshengli highphosphorylatedcyclindependentkinase2expressionindicatespoorprognosisofluminalandrogenreceptortriplenegativebreastcancerpcdk2inluminalandrogenreceptortnbc
AT linlin highphosphorylatedcyclindependentkinase2expressionindicatespoorprognosisofluminalandrogenreceptortriplenegativebreastcancerpcdk2inluminalandrogenreceptortnbc
AT zourenlong highphosphorylatedcyclindependentkinase2expressionindicatespoorprognosisofluminalandrogenreceptortriplenegativebreastcancerpcdk2inluminalandrogenreceptortnbc
AT sunge highphosphorylatedcyclindependentkinase2expressionindicatespoorprognosisofluminalandrogenreceptortriplenegativebreastcancerpcdk2inluminalandrogenreceptortnbc
AT zengkai highphosphorylatedcyclindependentkinase2expressionindicatespoorprognosisofluminalandrogenreceptortriplenegativebreastcancerpcdk2inluminalandrogenreceptortnbc
AT zhoubaosheng highphosphorylatedcyclindependentkinase2expressionindicatespoorprognosisofluminalandrogenreceptortriplenegativebreastcancerpcdk2inluminalandrogenreceptortnbc
AT tongyuxin highphosphorylatedcyclindependentkinase2expressionindicatespoorprognosisofluminalandrogenreceptortriplenegativebreastcancerpcdk2inluminalandrogenreceptortnbc
AT chenbo highphosphorylatedcyclindependentkinase2expressionindicatespoorprognosisofluminalandrogenreceptortriplenegativebreastcancerpcdk2inluminalandrogenreceptortnbc
AT zhaoyue highphosphorylatedcyclindependentkinase2expressionindicatespoorprognosisofluminalandrogenreceptortriplenegativebreastcancerpcdk2inluminalandrogenreceptortnbc